Forecasts

Help
Analyst
Ticker
Result
Analyst Action
AI Recommendation
Period
Limit
Return %
Filters
Performance Current: Return -4.96% • Success Rate 45.0%
Total: 27297 • Pg: 1022/1365 ← Back Next →
T AT&T
2026-03-10 • Arete Research
Δh% -19.49%
Rating Upgraded Hold
Price Then 27.71
Price h 22.31
Target 28
HIMS Hims & Hers Health
2026-03-10 • Deutsche Bank
Δh% -37.79%
Target Raised Sell
Price Then 23.47
Price h 14.6
Target 28
XENE Xenon Pharmaceuticals
2026-03-10 • Deutsche Bank
Δh% -38.89%
Target Raised Sell
Price Then 60.61
Price h 37.04
Target 90
BETA Beta Technologies (BETA)
2026-03-10 • Jefferies
Δh% -20.58%
Target Lowered Sell
Price Then 21.57
Price h 17.13
Target 29
GTLB GitLab
2026-03-09 • Morgan Stanley
Δh% 75.63%
Target Lowered Hold
Price Then 24.58
Price h 43.17
Target 29
GBTG Global Business Travel Group
2026-03-09 • Morgan Stanley
Δh% 64.93%
Target Lowered Sell
Price Then 5.76
Price h 9.5
Target 7
GBTG Global Business Travel Group
2026-03-09 • BTIG
Δh% 64.93%
Target Lowered Sell
Price Then 5.76
Price h 9.5
Target 9
DNTH Dianthus Therapeutics
2026-03-09 • UBS
Δh% 6.71%
Target Raised Hold
Price Then 79.23
Price h 84.55
Target 98
XENE Xenon Pharmaceuticals
2026-03-09 • RBC Capital
Δh% -40.98%
Target Raised Sell
Price Then 62.76
Price h 37.04
Target 80
XENE Xenon Pharmaceuticals
2026-03-09 • Jefferies
Δh% -40.98%
Target Raised Sell
Price Then 62.76
Price h 37.04
Target 100
DNTH Dianthus Therapeutics
2026-03-09 • Jefferies
Δh% 6.71%
Target Raised Hold
Price Then 79.23
Price h 84.55
Target 98
KEX Kirby Corporation
2026-03-09 • Evercore ISI
Δh% -2.32%
Update Sell
Price Then 125.81
Price h 122.89
Target 138
XENE Xenon Pharmaceuticals
2026-03-09 • Guggenheim
Δh% -40.98%
Target Raised Sell
Price Then 62.76
Price h 37.04
Target 90
CAH Cardinal Health
2026-03-09 • Leerink Partners
Δh% 22.73%
Update Hold
Price Then 222.28
Price h 272.81
Target 275
QURE UniQure
2026-03-09 • Chardan Capital
Δh% 7.56%
Target Raised Sell
Price Then 17.99
Price h 19.35
Target 31
DNTH Dianthus Therapeutics
2026-03-09 • Robert W. Baird
Δh% 6.71%
Target Raised Hold
Price Then 79.23
Price h 84.55
Target 132
XENE Xenon Pharmaceuticals
2026-03-09 • Morgan Stanley
Δh% -40.98%
Target Raised Sell
Price Then 62.76
Price h 37.04
Target 97
XENE Xenon Pharmaceuticals
2026-03-09 • Robert W. Baird
Δh% -40.98%
Target Raised Sell
Price Then 62.76
Price h 37.04
Target 97
PFE Pfizer
2026-03-09 • BMO Capital
Δh% 3.45%
Update Buy
Price Then 26.485
Price h 27.4
Target 30
HIMS Hims & Hers Health
2026-03-09 • Needham
Δh% -34.68%
Update Sell
Price Then 22.3501
Price h 14.6
Target 30
Date ↓ Analyst Stock Action AI at Time Price Then Price h Δh% Target Portfolio
2026-03-10 Arete Research
T AT&T
Rating Upgraded Hold 27.71 22.31 -19.49% 28
2026-03-10 Deutsche Bank
HIMS Hims & Hers Health
Target Raised Sell 23.47 14.6 -37.79% 28
2026-03-10 Deutsche Bank
XENE Xenon Pharmaceuticals
Target Raised Sell 60.61 37.04 -38.89% 90
2026-03-10 Jefferies
BETA Beta Technologies (BETA)
Target Lowered Sell 21.57 17.13 -20.58% 29
2026-03-09 Morgan Stanley
GTLB GitLab
Target Lowered Hold 24.58 43.17 75.63% 29
2026-03-09 Morgan Stanley
GBTG Global Business Travel Group
Target Lowered Sell 5.76 9.5 64.93% 7
2026-03-09 BTIG
GBTG Global Business Travel Group
Target Lowered Sell 5.76 9.5 64.93% 9
2026-03-09 UBS
DNTH Dianthus Therapeutics
Target Raised Hold 79.23 84.55 6.71% 98
2026-03-09 RBC Capital
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 37.04 -40.98% 80
2026-03-09 Jefferies
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 37.04 -40.98% 100
2026-03-09 Jefferies
DNTH Dianthus Therapeutics
Target Raised Hold 79.23 84.55 6.71% 98
2026-03-09 Evercore ISI
KEX Kirby Corporation
Update Sell 125.81 122.89 -2.32% 138
2026-03-09 Guggenheim
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 37.04 -40.98% 90
2026-03-09 Leerink Partners
CAH Cardinal Health
Update Hold 222.28 272.81 22.73% 275
2026-03-09 Chardan Capital
QURE UniQure
Target Raised Sell 17.99 19.35 7.56% 31
2026-03-09 Robert W. Baird
DNTH Dianthus Therapeutics
Target Raised Hold 79.23 84.55 6.71% 132
2026-03-09 Morgan Stanley
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 37.04 -40.98% 97
2026-03-09 Robert W. Baird
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 37.04 -40.98% 97
2026-03-09 BMO Capital
PFE Pfizer
Update Buy 26.485 27.4 3.45% 30
2026-03-09 Needham
HIMS Hims & Hers Health
Update Sell 22.3501 14.6 -34.68% 30